A novel dendritic cell-induced model of erosive inflammatory arthritis: Distinct roles for dendritic cells in T cell activation and induction of local inflammation

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 7071-7077

  Leung, Bernard P ^a   Conacher, Margaret ^a   Hunter, David ^a   McInnes, Iain B ^b   Liew, Foo Y ^a   Brewer, James M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN; IMMUNOGLOBULIN G; OVALBUMIN; RECEPTOR ANTIBODY; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR; CYTOKINE; EPITOPE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CELL FUNCTION; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; DBA MOUSE; DISEASE MODEL; HINDLIMB; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; COLLAGEN; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; HINDLIMB; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037114178     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.7071     Document Type: Article

References (47)

1. Klareskog, L., and H. McDevitt. 1999. Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactions. Curr. Opin. Immunol. 11:657.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
3. Mellman, I., S. J. Turley, and R. M. Steinman. 1998. Antigen processing for amateurs and professionals. Trends Cell Biol. 8:231.
4. Steinman, R. M. 2000. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100:491.
5. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
6. Thomas, R., L. S. Davis, and P. E. Lipsky. 1994. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J. Immunol. 152:2613.
7. Summers, K. L., J. L. O'Donnell, L. A. Williams, and D. N. Hart. 1996. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis. Arthritis Rheum. 39:1287.
8. Pettit, A. R., and R. Thomas. 1999. Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis? Immunol. Cell Biol. 77:420.
9. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
10. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47.
11. Traver, D., K. Akashi, M. Manz, M. Merad, T. Miyamoto, E. G. Engleman, and I. L. Weissman. 2000. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 290:2152.
12. Whelan, M., M. M. Harnett, K. M. Houston, V. Patel, W. Harnett, and K. P. Rigley. 2000. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 164:6453.
13. Bottomly, K. 1999. T cells and dendritic cells get intimate. Science 283:1124.
14. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
15. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978.
16. Inaba, K., M. Inaba, M. Naito, and R. M. Steinman. 1993. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guérin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479.
17. Steinman, R. M., and J. Swanson. 1995. The endocytic activity of dendritic cells. J. Exp. Med. 182:283.
18. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class-II compartment - down-regulation by cytokines and bacterial products. J. Exp. Med. 182:389.
19. Rescigno, M., F. Granucci, S. Citterio, M. Foti, and P. Ricciardi-Castagnoli. 1999. Coordinated events during bacteria-induced DC maturation. Immunol. Today 20:200.
20. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
21. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
22. Knight, S. C., J. Mertin, A. Stackpoole, and J. Clark. 1983. Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc. Natl. Acad. Sci. USA 80:6032.
23. Inaba, K., M. Pack, M. Inaba, H. Sakuta, F. Isdell, and R. M. Steinman. 1997. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186:665.
24. Dittel, B. N., I. Visintin, R. M. Merchant, and C. A. Janeway, Jr. 1999. Presentation of the self-antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163:32.
25. Brewer, J. M., and J. Alexander. 1997. Cytokines and the mechanisms of action of vaccine adjuvants. Cytokines Cell. Mol. Ther. 3:233.
26. Schijns, V. E. 2000. Immunological concepts of vaccine adjuvant activity. Curr. Opin. Immunol. 12:456.
27. Leung, B. P., I. B. McInnes, E. Esfandiari, X. Q. Wei, and F. Y. Liew. 2000. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J. Immunol. 164:6495.
28. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77.
29. + T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 165:6590.
30. Joosten, L. A., E. Lubberts, P. Durez, M. M. Helsen, M. J. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249.
31. + T cells. J. Exp. Med. 185:2133.
32. Waseem, N. H., and D. P. Lane. 1990. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nucleolar form. J. Cell Sci. 96: 121.
33. Smeets, T. J., R. J. Dolhain, F. C. Breedveld, and P. P. Tak. 1998. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J. Pathol. 186:75.
34. Davis, L. S., M. Sackler, R. I. Brezinschek, E. Lightfoot, J. L. Bailey, N. Oppenheimer-Marks, and P. E. Lipsky. 2002. Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis. Am. J. Pathol. 160:357.
35. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.
36. Pearson, C. I., and H. O. McDevitt. 1999. Redirecting Th1 and Th2 responses in autoimmune disease. Curr. Top. Microbiol. Immunol. 238:79.
37. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
38. Thorbecke, G. J., R. Shah, C. H. Leu, A. P. Kuruvilla, A. M. Hardison, and M. A. Palladino. 1992. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 89:7375.
39. Marinova-Mutafchieva, L., R. O. Williams, C. Mauri, L. J. Mason, M. J. Walmsley, P. C. Taylor, M. Feldmann, and R. N. Maini. 2000. A comparative study into the mechanisms of action of anti-tumor necrosis factor α anti-CD4, and combined anti-tumor necrosis factor α/anti-CD4 treatment in early collagen-induced arthritis. Arthritis Rheum. 43:638.
40. O'Garra, A., and K. Murphy. 1996. Role of cytokines in development of Th1 and Th2 cells. Chem. Immunol. 63:1.
41. Stuart, J. M., A. S. Townes, and A. H. Kang. 1984. Collagen autoimmune arthritis. Annu. Rev. Immunol. 2:199.
42. Holmdahl, R., L. Jansson, M. Andersson, and E. Larsson. 1988. Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology 65:305.
43. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249.
44. Cumberbatch, M., R. J. Dearman, and I. Kimber. 1997. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology 92:388.
45. Saeki, H., A. M. Moore, M. J. Brown, and S. T. Hwang. 1999. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162:2472.
46. Sedgwick, J. D., D. S. Riminton, J. G. Cyster, and H. Komer. 2000. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol. Today 21:110.
47. Maini, R. N., P. C. Taylor, E. Paleolog, P. Charles, S. Ballara, F. M. Brennan, and M. Feldmann. 1999. Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. Ann. Rheum. Dis. 58(Suppl. 1):156.